Reflecting on the Future: Outlook Therapeutics Shares Financial Results for Q3 of FY 2024 and Exciting Corporate Updates

Reflecting on the Future: Outlook Therapeutics Shares Financial Results for Q3 of FY 2024 and Exciting Corporate Updates Exciting News from Outlook Therapeutics ISELIN, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that has achieved regulatory approval in the EU and UK for the first authorized use of…

Read More

Cardinal Health Soars to New Heights: Fourth Quarter and Fiscal Year 2024 Results Released and Fiscal Year 2025 Guidance Raised

Cardinal Health Reports Record Fourth Quarter Revenue Overview In a recent press release, Cardinal Health announced that its fourth quarter revenue for fiscal year 2024 increased by 12% to $59.9 billion. The company also disclosed that their GAAP operating earnings were $401 million, with a GAAP diluted EPS of $0.96. Additionally, non-GAAP operating earnings saw…

Read More

Lightspeed Launches Retail Insights to Boost Sales and Reduce Inventory Risks

Lightspeed Commerce Inc. Launches Retail Insights: A Game-Changer for Retailers Revolutionizing the Retail Industry Lightspeed Commerce Inc. has once again proven itself to be a trailblazer in the retail industry with the launch of Retail Insights. This innovative product offers data-driven insights that forecast sales opportunities and inventory management issues, providing business owners with the…

Read More

LuxUrban Hotels: First Tranche of Private Placement Closed for Senior Secured Convertible Notes and Common Stock Purchase Warrants

Welcome to the LuxUrban Hotels Blog! Exciting News from LuxUrban Hotels Inc. MIAMI, Aug. 13, 2024 (GLOBE NEWSWIRE) — LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), which secures long-term operating rights for entire hotels through Master Lease Agreements (MLA), today announced that it has closed the first tranche of a private offering to…

Read More